Tackling Coronavirus: The role of Roquette’s KLEPTOSE® Hydroxypropyl β-cyclodextrin in the fight against COVID-19
Published January 27, 2026
Hydroxypropyl β-cyclodextrin has been shown to be effective as solubilizing and stabilizing agents in vaccines, monoclonal antibodies, and oral formulations.
Speakers
Wen Chin Foo
Pharmaceutical Scientist, Pharmaceutical R&D, Roquette
Tao Peng
BioPharma Research Manager, Roquette Asia Pacific Pte Ltd, 138588 Singapore
Watch our expert video, featuring Pharma and BioPharma Scientists – Dr. Foo Wen Chin and Dr. Peng Tao – who explain how Roquette’s KLEPTOSE® HPβCD may be used to support the efforts of the scientific and pharmaceutical communities looking to develop drugs for the treatment and prevention of new emerging viruses, such as the coronavirus. Here, they discuss various treatment strategies and the potential role of cyclodextrins as an excipient and adjuvant.
